Results 161 to 170 of about 7,044 (182)
Some of the next articles are maybe not open access.
BML-11, A Lipoxin Receptor Agonist, Protected Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats
Inflammation, 2013Inflammation plays an important role in the occurrence and development of fibrosis. Lipoxins (LXs) and BML-111 (lipoxin A4 agonist) have been approved for potent anti-inflammatory properties. Previously, we and others had showed LXs and BML-111 could protect acute hepatic injury, inhibit the growth and invasion of hepatic tumor.
Xiao-Yan, Zhou +8 more
openaire +2 more sources
Cell‐Cell Interactions in Lipoxin Generation and Characterization of Lipoxin A4 Receptorsa
Annals of the New York Academy of Sciences, 1994C N, Serhan, S, Fiore, B D, Levy
openaire +2 more sources
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease
Cell Metabolism, 2015Emma Börgeson +2 more
exaly
Effects of Lipoxin A4 (LX) on Glucocorticoid Receptor (gr) Function
Journal of Allergy and Clinical Immunology, 2007J.M. Terasaki +3 more
openaire +1 more source
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
Nature Immunology, 2004Christopher L Karp +2 more
exaly